It is important to promote the ongoing development of best practices for integrated specialty pharmacies in academic health systems. Despite the challenges reviewed, we offer strategies to overcome these barriers. As specialty pharmacy continues to grow, we strongly encourage other programs to share best...
3 The US Food and Drug Administration analyzed pooled data4 from the extension phase of major bisphosphonate clinical trials5-7 and concluded that the benefits of continued treatment beyond 3 to 5 years remained unclear. A retrospective Women’s Health Initiative (WHI) study of women who self-...